Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Interleukin-1-receptor antagonist (IL-1RA) modulates the biological activity of the proinflammatory cytokine interleukin-1 (IL-1) and could play an important role in the pathophysiology of inflammatory and metabolic traits. We genotyped seven single nucleotide polymorphisms (SNPs) that capture a large proportion of common genetic variation in the IL-1RN gene in 1256 participants from the Invecchiare in Chianti study. We identified five SNPs associated with circulating IL-1RA levels with varying degrees of significance (P-value range=0.016-4.9 x 10(-5)). We showed that this association is likely to be driven by one haplotype, most strongly tagged by rs4251961. This variant is only in weak linkage disequilibrium (r(2)=0.25) with a previously reported variable number of tandem repeats polymorphism (VNTR) in intron-2 although a second variant, rs579543, that tags the VNTR (r(2)=0.91), may also be independently associated with IL-1RA levels (P=0.03). We found suggestive evidence that the C allele at rs4251961 that lowers IL-1RA levels is associated with an increased IL-1beta (P=0.03) level and may also be associated with interferon -gamma (P=0.03), alpha-2 macroglobulin (P=0.008) and adiponectin (P=0.007) serum levels. In conclusion, common variation across the IL-1RN gene is strongly associated with IL-1RA levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Examining common variants of the IL1RN gene revealed that the rs4251961 minor allele is associated with a lowered serum level of IL-1RN and that the rs579543 single nucleotide polymorphism (SNP) is also independently associated with IL-1RN levels, whereas the IL1RN 1018 haplotype correlates with higher concentrations of IL-1β and IFNγ22.”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [22]
In the citing paper
“Examining common variants of the IL1RN gene revealed that the rs4251961 minor allele is associated with a lowered serum level of IL-1RN and that the rs579543 single nucleotide polymorphism (SNP) is also independently associated with IL-1RN levels, whereas the IL1RN 1018 haplotype correlates with higher concentrations of IL-1β and IFNγ22.”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [22]
Citations
Cites
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Haplotype tagging for the identification of common disease genes
Johnson, G. C. L., Esposito, L., Barratt, B. J., Smith, A. N., Heward, J., Di Genova, G., Ueda, H., Cordell, H. J., Eaves, I. A., Dudbridge, F., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-233 · Cited by 1,174
Pedigree disequilibrium tests for multilocus haplotypes.
Dudbridge, F. (2003) · Genetic Epidemiology · doi:10.1002/gepi.10252 · Cited by 1,135
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025
The origins of age-related proinflammatory state
Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S., Bartali, B., Taub, D. D., Guralnik, J. M., & Longo, D. L. (2005) · Blood · doi:10.1182/blood-2004-07-2599 · Cited by 908
Self-citationInflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study
Cesari, M., Penninx, B. W. J. H., Pahor, M., Lauretani, F., Corsi, A. M., Williams, G. R., Guralnik, J. M., & Ferrucci, L. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m242 · Cited by 901
Self-citationFerrucci, L., Bandinelli, S., Benvenuti, E., Di Iorio, A., Macchi, C., Harris, T. B., & Guralnik, J. M. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb03873.x · Cited by 804
Self-citationBruun, J. M., Lihn, A. S., Verdich, C., Pedersen, S. B., Toubro, S., Astrup, A., & Richelsen, B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00110.2003 · Cited by 775
Danis, V. A., Millington, M., Hyland, V. J., & Grennan, D. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb05549.x · Cited by 530
Vasseur, F. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2607 · Cited by 495
Biasucci, L. M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A. G., Ginnetti, F., Dinarello, C. A., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.16.2079 · Cited by 485
Hurme, M., & Santtila, S. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199808)28:08<2598::aid-immu2598>3.0.co;2-k · Cited by 430
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay, C., Smith, M. F., Eidlen, D., & Arend, W. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119488 · Cited by 319
Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene
Nicklin, M. J. H., Hughes, D. E., Barton, J. L., Ure, J. M., & Duff, G. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.303 · Cited by 317
Influence of Interleukin‐1 Receptor Antagonist Gene Polymorphism on Disease
Witkin, S. S., Gerber, S., & Ledger, W. J. (2002) · Clinical Infectious Diseases · doi:10.1086/338261 · Cited by 301
The role of interleukin 1 in growth and metastasis of human cancer xenografts.
Elaraj, D. M., Weinreich, D. M., Varghese, S., Puhlmann, M., Hewitt, S. M., Carroll, N. M., Feldman, E. D., Turner, E. M., & Alexander, H. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1603 · Cited by 288
Proinflammatory state and circulating erythropoietin in persons with and without anemia
Ferrucci, L., Guralnik, J. M., Woodman, R. C., Bandinelli, S., Lauretani, F., Corsi, A. M., Chaves, P. H. M., Ershler, W. B., & Longo, D. L. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.039 · Cited by 240
Self-citationInterleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes.
Stylianou, E., O'Neill, L. A., Rawlinson, L., Edbrooke, M. R., Woo, P., & Saklatvala, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49611-7 · Cited by 211
Physiologic role of interleukin-1 receptor antagonist.
Arend, W. P., & Gabay, C. (2000) · Arthritis Research · doi:10.1186/ar94 · Cited by 131
Patterns of inflammation associated with peripheral arterial disease: The InCHIANTI study
McDermott, M. M., Guralnik, J. M., Corsi, A., Albay, M., Macchi, C., Bandinelli, S., & Ferrucci, L. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.09.032 · Cited by 118
Self-citationAbbatecola, A. M., Ferrucci, L., Grella, R., Bandinelli, S., Bonafè, M., Barbieri, M., Corsi, A. M., Lauretani, F., Franceschi, C., & Paolisso, G. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52112.x · Cited by 116
Self-citationDecreased Fat Mass in Interleukin-1 Receptor Antagonist–Deficient Mice
Somm, E., Henrichot, E., Pernin, A., Juge-Aubry, C. E., Muzzin, P., Dayer, J.-M., Nicklin, M. J. H., & Meier, C. A. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3503 · Cited by 114
Lacquemant, C., Froguel, P., Lobbens, S., Izzo, P., Dina, C., & Ruiz, J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01224.x · Cited by 114
Pollin, T. I., Tanner, K., O’Connell, J. R., Ott, S. H., Damcott, C. M., Shuldiner, A. R., McLenithan, J. C., & Mitchell, B. D. (2005) · Diabetes · doi:10.2337/diabetes.54.1.268 · Cited by 107
Carter, M. J., di Giovine, F. S., Jones, S., Mee, J. B., Camp, N. J., Lobo, A. J., & Duff, G. W. (2001) · Gut · doi:10.1136/gut.48.4.461 · Cited by 72
Marculescu, R., Endler, G., Schillinger, M., Iordanova, N., Exner, M., Hayden, E., Huber, K., Wagner, O., & Mannhalter, C. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3582 · Cited by 70
Interleukin-1 System Gene Polymorphisms Are Associated with Fat Mass in Young Men
Strandberg, L., Lorentzon, M., Hellqvist, A., Nilsson, S., Wallenius, V., Ohlsson, C., & Jansson, J.-O. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2786 · Cited by 50
Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease
Vijgen, L., Gysel, M. V., Rector, A., Thoelen, I., Esters, N., Ceelen, T., Vangoidsenhoven, E., Vermeire, S., Rutgeerts, P., & Ranst, M. A. V. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363888 · Cited by 29
Fiocco, U., Vezzù, M., Cozzi, L., & TODESCO, S. (2011) · Reumatismo · doi:10.4081/reumatismo.2004.1s.62 · Cited by 11
Cited by
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Anti-inflammatory Agents: Present and Future
Dinarello, C. A. (2010) · Cell · doi:10.1016/j.cell.2010.02.043 · Cited by 1,095
The Role of Cytokines in Breast Cancer Development and Progression
Esquivel-Velázquez, M., Ostoa-Saloma, P., Palacios-Arreola, M. I., Nava-Castro, K. E., Castro, J. I., & Morales-Montor, J. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0026 · Cited by 490
A genome-wide association study identifies protein quantitative trait loci (pQTLs)
Melzer, D., Perry, J. R. B., Hernandez, D., Corsi, A.-M., Stevens, K., Rafferty, I., Lauretani, F., Murray, A., Gibbs, J. R., Paolisso, G., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000072 · Cited by 480
Self-citationSustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., & Mandrup-Poulsen, T. (2009) · Diabetes Care · doi:10.2337/dc09-0533 · Cited by 401
Metadata
- Authors
- Rafiq, S., Stevens, K., Hurst, A. J., Murray, A., Henley, W., Weedon, M. N., Bandinelli, S., Corsi, A. M., Guralnik, J. M., Ferruci, L., Melzer, D., & Frayling, T. M.
- Affiliations
- University of Exeter (GB)
- Peninsula College of Medicine and Dentistry (GB)
- University of Plymouth (GB)
- National Research Council (IT)
- University of Florence (IT)
- National Institutes of Health (US)
- Corresponding author
- Frayling, T M
- ORCID
- Venue
- Genes & Immunity
- Published
- 2007-04-19
- Volume
- 8
- Issue
- 4
- Pages
- 344-351
- ISSN
- 1466-4879 (ISSN-L)
- 1476-5470
- OpenAlex
- W2026094781
- Cited by
- 92
- References
- 31
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 7 · 2022: 7 · 2021: 3 · 2020: 1 · 2019: 6 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 5 · 2014: 7 · 2013: 7 · 2012: 5
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Genes and Immunity (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (N01AG-821336, N01[AG]916413, R01 AG 24233-01, R01AG024233)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- interleukin-1 receptor antagonist, single nucleotide polymorphisms, genetic association, haplotypes, variable number tandem repeats, IL-1β, interferon-gamma, adiponectin, alpha2-macroglobulin, inflammation, metabolic phenotypes
- MeSH terms
- Aged, Aged, 80 and over, Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Humans, Italy, Male, Middle Aged, Genetic Variation, Polymerase Chain Reaction, Minisatellite Repeats, Polymorphism, Single Nucleotide, Interleukin 1 Receptor Antagonist Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.